| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.2 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |